ArticleOncoTargets and therapy2018
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
Jun Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it